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SHAPING THE REVOLUTION: THORACIC SURGEONS AND SOMETHING MORE 
David B. Skinner, MD 
H istorians in the audience will recognize that this title is adapted from Julian Johnson's 1963 pres- 
idential address) Dr. Johnson recognized the revo- 
lution that had been taking place in the 1950s and 
1960s, which brought science and research into the 
mainstream of clinical medicine. This in turn per- 
mitted the maturation of thoracic surgery into a 
scientific discipline and a true specialty. In this 
revolution, which placed research at the apex after 
the Second World War, Dr. Johnson pled that 
operating clinical surgeons hould take a leadership 
role in research and teaching, as well as in clinical 
surgery. By so doing, thoracic surgeons became 
surgeons and something more. 
In times of rapid change or revolution, it takes 
leadership to shape the revolution into an orderly 
transition without overthrowing the best of the 
From the Department of Surgery, New York Hospital-Cornell 
Medical Center, New York, N.Y. 
Read at the Seventy-seventh Annual Meeting of The American 
Association for Thoracic Surgery, Washington, D.C., May 4-7, 
1997. 
Received for publication May 21, 1997; accepted for publication 
June 5, 1997. 
Address for reprints: David B. Skinner, MD, Department of 
Surgery, New York Hospital-Cornell Medical Center, 525 
East 68th St., New York, NY 10021. 
J Thorac Cardiovasc Surg 1997;114:699-706 
Copyright © 1997 by Mosby-Year Book, Inc. 
0022-5223/97 $5.00 + 0 12/6/83906 
previous era--hence Dr. Johnson's plea that oper- 
ating clinical surgeons take the leadership role 
rather than turning it over to nonoperating research 
professors, as happened in some of the medical 
disciplines. 
During turbulent imes it is especially helpful to 
have mentors who, leading by example, make it all 
right to follow different and unconventional path- 
ways. Fortunately we in thoracic surgery have had 
several such mentors during the 1940s to 1960s who 
guided the introduction of serious research and 
science into clinical surgery. These mentors encour- 
aged a number of recent presidents of this Associ- 
ation and other current leaders in thoracic surgery 
to be "surgeons and something more." Today tho- 
racic surgeons must provide leadership in shaping 
the outcome of the present health care revolution, 
which we are surely in. For me and many others, a 
special mentor was Edward D. Churchill, chief of 
surgery at the Massachusetts General Hospital 
(MGH) from 1931 to 1961 and the John Homans 
Professor of Surgery at Harvard Medical School. 
I was first introduced to Dr. Churchill and the 
MGH during my senior year at Yale Medical 
School, where the influence of Gustaf Lindskog and 
Bill Glenn stimulated and developed my life-long 
interest in thoracic surgery. Dr. Lindskog was a 
master clinician, anatomist, and an advocate of 
cross-disciplinary scientific efforts combining pathol- 
ogy, radiology, and pulmonary medicine with tho- 
699 
7 0 0 Skinner 
The Journal of Thoracic and 
Cardiovascular Surgery 
November 1997 
racic surgery to advance the field and provide su- 
perb opportunities in education. Dr. Glenn was a 
clear advocate and exponent of basic surgical re- 
search and applied it directly to clinical problems, 
hence leading to the development of the Glenn 
operation and an early membrane oxygenator while 
I was at Yale. Both of these two giants in Yale 
surgery were trainees of Edward Churchill, and they 
not only encouraged me but made it possible for me 
to go to the MGH. I was told at the time that I was 
the first Yale student ever to go to the MGH 
surgical residency and was known in Boston as "The 
Metastasis" for several years. 
The MGH in 1959 was an exciting place, as it is to 
this day, reflecting Dr. Churchill's philosophy of 
education. He assembled an all-star group of surgi- 
cal giants, each an international leader in his respec- 
tive field. Somehow Dr. Churchill's leadership al- 
lowed for the emergence of these prima donnas and 
had them working together with a superb house 
staff. The diversity of the MGH surgical leaders and 
the rectangular nature of the residency program 
allowed for people of many varying interests to work 
side by side and provided the opportunity to com- 
plete the residency program to individuals with 
widely divergent viewpoints. Dr. Churchill allowed 
not only his peers but the residents themselves to 
teach and lead each other, a significant and uncon- 
ventional break from the traditional Halsted pyra- 
midal program. 2 Thus two of my most important 
teachers in the first 2 years of my residency were 
George Zuidema and Gerry Austen, who served as 
chief residents on the East Surgical Service during 
those years. 
Professor Churchill was unconventional in ways 
that broadened the outlook of his associates and 
made it all right for his students to pursue careers 
evolving into different pathways and preparing them 
intellectually to be able to deal with radical change, 
which has been a constant in recent years. First of 
all, Dr. Churchill was a pioneering thoracic surgeon. 
He is credited with the first pericardiectomy in this 
country, early esophageal nd parathyroid surgery, 
and he was a major developer of the anatomic 
pulmonary resection. He attracted outstanding tho- 
racic surgery fellows, including Lindskog, Max 
Chamberlain, and Ronald Belsey. In 1939, Churchill 
and Belsey 3published the first descriptions of seg- 
mental resection of the lung and established the 
pulmonary segment as the key anatomic unit of the 
lung. During the Second World War, Colonel 
Churchill was the surgical consultant to the Fifth 
Army in the Mediterranean theater. After the war, 
the surgeon general referred to Dr. Churchill as 
"The man who has done the most outstanding work 
in the development of military surgery in the war .  ' '4 
Truly a thoracic surgeon and something more. 
Churchill's early pioneering work in several fields 
was followed up by colleagues uch as past presi- 
dents of this Association Gordon Scannell in pul- 
monary surgery, Gerry Austen and Mort Buckley in 
cardiac surgery, and Richard Sweet in esophageal 
surgery. It was while I was serving as a resident for 
Dr. Sweet that my first interest in esophageal sur- 
gery was stimulated. My interest led Dr. Churchill to 
arrange for me to spend a definitive year in my life 
at Frenchay Hospital under the guidance of Ronald 
Belsey. 
Ronald Belsey has been not only my clinical and 
scientific mentor in thoracic surgery but one of my 
closest friends and a personal mentor to me and our 
family. After his fellowship with Professor Churchill 
at the MGH, Mr. Belsey served as a surgeon at St. 
Mary's Hospital in London during the Second 
World War. He then became the first consultant 
thoracic surgeon in southwest England at the spe- 
cialized thoracic unit at Frenchay Hospital, where 
he remained until 1975, when he joined me for 12 
years as visiting professor at the University of Chi- 
cago. During the Frenchay ears a number of North 
American surgical residents from the MGH, the 
University of Toronto, and The Johns Hopkins 
Hospital had the opportunity to serve as senior 
registrar or registrar on Mr. Belsey's service. His 
impact on the evolution of American thoracic sur- 
gery and especially esophageal surgery has been 
enormous. 
Although best known for his contributions to 
esophageal surgery, such as the Belsey Mark IV 
antireflux procedure, 5 isoperistaltic left colon inter- 
position, 6the exclusive right thoracotomy approach 
for esophagogastrectomy, 7 esophagomyotomy, and 
diverticulopexy for Zenker's diverticulum, s and 
many others, Mr. Belsey was also a major contribu- 
tor to pulmonary surgery, describing segmental re- 
section of the lung 58 years ago with Churchill 3 and 
describing a successful technique for total tracheal 
replacement. 9 It is not as widely known that he was 
also a pioneering cardiac surgeon with an early 
experience inprofound hypothermia and circulatory 
arrest for the correction of congenital heart anom- 
alies) ° Mr. Belsey became an honorary fellow of 
The American Association for Thoracic Surgery in 
1966 and is here with us today as my special guest 58 
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years after his landmark article in pulmonary sur- 
gery. 
Many of Dr. Churchill's residents became tho- 
racic surgeons and something more, following in his 
footsteps. Those of us who became department 
chairs were clearly influenced by and adopted iver- 
sity in our faculty and residency programs. This in 
turn has encouraged growth in others. I am pleased 
that seven colleagues from my chairmanship atthe 
University of Chicago are now university depart- 
ment chairs in this country and twelve former resi- 
dents are providing leadership in cardiac or thoracic 
surgery programs. Overseas, a number of fellows 
have become department chairs or heads of thoracic 
surgery divisions. The Churchill legacy continues 
and provides us with the courage and resources to 
address the current health care revolution. 
To understand the revolution that we are cur- 
rently experiencing, it is helpful to put it into the 
perspective of the previous health care revolution 
this century. Before World War II medicine was 
based almost entirely on clinical observations and 
experiences. Almost no research was being done, 
and responsibility for health care delivery had no 
nationally organized basis. With varying levels of 
support, communities and sometimes tates ac- 
cepted some health care responsibilities, mainly for 
public health. During these times access was widely 
available through a variety of health care practitio- 
ners. Nearly every small town had a local doctor of 
some sort. Quality in the absence of science was 
poor, and costs were not great. 
The first major revolution of this century came in 
the 1950s and 1960s, when scientific discoveries 
began to dominate the practice of medicine and the 
federal government began investing heavily in bio- 
medical research. As a scientific basis for treatments 
became available, clinical experience counted for 
less. 
Societal interest became involved in the mid- 
1960s with the establishment of Medicaid and Medi- 
care as national programs, but these initially exerted 
very little control over the usual patterns of physi- 
cian and hospital practice. As the impact of research 
became apparent, quality revolved to the top of the 
pyramid. Costs still remained relatively low, and 
access was expanded by the federal programs. Dur- 
ing the 1980s the surge of scientific discoveries 
continued but cost began to rise sharply, thereby 
denying access to the uninsured and underinsured. 
This has led to the revolution we are experiencing in 
the 1990s. 
If this revolution succeeds, societal interest will 
revolve to the top of the pyramid. Decisions will be 
made on what is good for the population at large 
rather than for the individual. Restraints on costs 
will make research less supported. Concerns about 
cost become paramount and quality may decline 
along with the research investment. Our challenge 
today is to maintain the triangle with quality at the 
apex. If this is to be done, cost must be addressed 
and access extended to the entire population. If cost 
and access can be addressed, then quality and the 
progress of medical science will continue, and this 
undesirable revolution of the triangle will be 
avoided. 
Without question, rising health costs are driving 
this revolution. It is corporate America, finding 
more and more of its pre-tax profits going for health 
benefits, which has become the engine driving the 
revolution. Similar forces are at work elsewhere in 
the world. 11 
With the failure of the Clinton plan, societal 
concerns about access have been set aside in the 
rush to hold down cost. Only physicians and hospi- 
tals are concerned about quality and must also deal 
with providing care to anyone who needs it. To bring 
cost under control and maintain quality and access, 
networks are forming between patients and health 
care providers with regionalization f tertiary care. 
This requires a close alliance between doctors and 
hospitals. 
The New York Hospital-Cornell Medical Center 
was an early entrant into the battle to preserve 
quality while reducing cost and maintaining access. 
In late 1987 and 1988 when I first arrived as the 
president and chief executive officer of The New 
York Hospital, losses were exceeding 1 million 
dollars a week. The only option was to bring cost 
under control while everyone correctly insisted that 
quality be maintained. The solution was obtained 
after detailed analyses of true cost demonstrated 
that only physicians have control of the cost of 
hospitalization through their decisions about order- 
ing tests, procedures, and treatments and through 
their ability to control the length of stay, thus 
determining the amount of routine hotel and nurs- 
ing expenses per patient or diagnosis. 
Having determined the true cost of care, we were 
then able to provide data to every service and every 
physician comparing the revenue per case to the cost 
per case. For example, during 1988, while major 
losses were occurring, the cardiothoracic service, 
having a high revenue per case, was encouraged to
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increase its volume, which Dr. Isom and his col- 
leagues did. When the cost data were determined, it 
was learned that each new case of coronary artery 
bypass was losing an additional $5500 for the hos- 
pital. Rather than close the cardiothoracic service, 
Dr. Isom and colleagues quickly found ways in which 
the use of ancillaries and length of stay could be 
reduced. Quality was closely monitored and actually 
improved such that the risk-adjusted mortality for 
cardiac surgery at New York-Cornell became the 
lowest in the state and, in 1 year in the early 1990s, 
was the lowest in the United States. Initially the 
motivation for physicians to lead the way in reducing 
cost was the terror factor of potentially losing their 
hospital. Later, as economic balance and gains from 
operation were achieved, a system of incentives for 
the departments omeet targets was introduced and 
maintained physician interest. 
Efforts to improve efficiencies and quality have 
been sustained and supplemented by hospital-wide 
reengineering, again to improve efficiency and qual- 
ity. The result has been a steady annual improve- 
ment in the operating performance of the institu- 
tion. 
A recent example carried out on Dr. Isom's 
cardiothoracic service by Dr. Ferdi Velasco and 
others 12 during a fellowship was a detailed analysis 
of delays and inefficiencies in coronary artery bypass 
with and without catheterization. Once the analysis 
was complete, efforts involving the entire staff in- 
cluding nursing and nonprofessional personnel were 
undertaken. Over a 4-month time the length of stay 
for a patient undergoing bypass without catheteriza- 
tion dropped from 81/2 to 7 days. When catheteriza- 
tion was done during the hospitalization, lack of 
coordination had driven the length of stay up to 12 
days compared with 8 when the catheterization had 
been done previously. Streamlining the process and 
following newly devised pathways lowered the 
length of stay for coronary bypass with catheteriza- 
tion to 8 days, only 1 day greater than expected for 
coronary bypass without catheterization. Once 
again~ only the: physicians can make this happen. 
'Today clinical pathways, a form of medical reengi- 
neering; are being developed and widely adopted in 
many institutions including mine. The results are 
dramatic, with an overall 14% reduction achieved 
for coronary bypass procedures in the use of ancil- 
laries and a significant reduction in the length of stay 
with no sacrifice of quality. 
From many examples and measured in many 
ways, we have concluded that quality care is less 
expensive care. 13 This is achieved by getting the 
correct diagnosis and the right treatment with the 
fewest ests and fewer interventions, and it can be 
achieved by cooperation among the physicians and 
hospitals to avoid duplication and delays that are so 
expensive. This being understood, it is now clear 
that the cost-based revolution can be controlled by 
the physicians, who are capable of reducing cost 
without sacrifice of quality. To achieve this, all of us 
must be surgeons and something more. The results 
of these efficiencies and improved care must be built 
into our education system as much as we have built 
the science revolution into physician education. 
Besides our responsibilities to control cost while 
maintaining quality, many other aspects of the cur- 
rent revolution create choices that we as thoracic 
surgeons must make or be involved in. In the 
previous generations, cardiothoracic surgery sepa- 
rated from general surgery. The forces encouraging 
specialization are strong and were almost unop- 
posed over recent decades. They were driven espe- 
cially by the expanded knowledge and technologic 
base. Now we are once again facing choices as to 
whether our discipline should fragment further into 
general thoracic surgery, surgery for congenital 
heart disease, and surgery for acquired adult cardiac 
disease or whether it should remain unified. We are 
facing the pressures that managed care entities do 
not seek the benefits from multiple specialists. This 
exposes our discipline to losing some of its content, 
especially general thoracic surgery returning to the 
broader field of general surgery. 
These tensions between fragmentation and unifi- 
cation will ultimately be decided first at the individ- 
ual institutional level. Hence all cardiothoracic sur- 
geons must be involved in these choices about the 
future nature of our field. The current effort to 
separate vascular surgery from cardiovascular sur- 
gery on the one hand and general surgery on the 
other hand is only the most recent crisis demanding 
our attention in this regard. Esophageal, pulmonary, 
and chest rauma surgery are very much in jeopardy. 
If you do not fight and win the battle to your 
satisfaction at home, eventually it will be lost nation- 
ally as well. 
Every discipline stands at risk to the inevitable 
changing patterns of disease and to technologic 
developments hat provide alternatives to conven- 
tional treatment. Our discipline seems particularly 
vulnerable to prevention of both cardiovascular nd 
neoplastic diseases. On the other hand, an increased 
demand for thoracic surgery may result from in- 
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creasing trauma, pollution-induced pulmonary dis- 
ease, resurgence of other infections, and increasing 
demand for cardiac transplantation r the introduc- 
tion of artificial hearts. For the esophageal surgeon, 
reoperative surgery continues to require thoracic 
surgical expertise as more and more esophageal 
surgery is done by surgeons without much expertise 
in the field. 
Technologic developments also are changing the 
nature of cardiothoracic surgery. Further refine- 
ments in percutaneous and endoscopic techniques, 
balloon catheters, stents, laser treatments, and the 
well-established trend toward less invasive opera- 
tions are already reshaping the armamentarium of
thoracic surgery. Many diseases now treated by 
standard open surgery will be managed by alternate 
means in the near future. 
These changes in disease patterns and technologic 
treatments raise the question of redefining the role 
of the surgeon. Are we defined as physicians who 
use the operating room, or are we defined as 
physicians who have expertise in diseases typically 
treated by surgery, or will we adapt to being physi- 
cians having a range of treatment modalities defined 
by the diseases we treat rather than by the technol- 
ogy? For maximal flexibility, thoracic surgeons 
should emphasize the study of the diseases of the 
chest and their pathophysiology and acquire skills 
for treatments both inside and outside the operating 
room. Thoracic surgeons must provide leadership 
for multiple specialty teams that can work as a team 
for the benefit of the patient. Today, with so many 
competing treatments, the patient is often forced to 
choose between competing therapies without suffi- 
cient knowledge and without rue informed consent. 
For the sake of the patient, we must become tho- 
racic surgeons and something more. 
For the benefit of patients and to improve the 
quality of care, we at The New York Hospital- 
Cornell Medical Center and Columbia-Presbyterian 
Medical Center are exploring the restructuring of 
the medical organization with emphasis placed on 
diseases rather than traditional hospital depart- 
ments. Restructuring by disease cluster brings to- 
gether all of the physicians from multiple disciplines 
who have an expertise in a particular field such as 
lung cancer or coronary heart disease. These physi- 
cians would function together as a team, being in 
close geographic proximity both for inpatients and 
outpatients and providing continuity of care and 
shortened hospital stays. This focuses the expertise 
so that decisions can be made in the best interest of 
the patient rather than on the basis of competing 
specialties and technologies. The cluster of physi- 
cians treating a particular disease would be in a 
position to assess overall demand and determine the 
optimal number of doctors working together in 
teams. This allows physicians to address the ques- 
tion of excess capacity. Such a disease cluster struc- 
ture is ideal for capitation in the managed care 
market, with incentives being in place for efficien- 
cies. Such clusters make the marketing of centers of 
excellence a reality. A basic discipline of surgery or 
medicine needs to be maintained for student and 
first- and second-year residency education, but ad- 
vanced residency education and fellowships would 
be enhanced by the advanced trainee having access 
to the spectrum of expertise concerning major dis- 
eases. 
A reorganization by disease cluster could include 
a broad spectrum of functional groups. Surgeons 
and other specialists might participate in several 
groups on a percentage of time basis. In such a 
restructuring the revenues would be billed and 
collected on the basis of the disease cluster. This 
approach lends itself to structuring prospective fixed 
payment amounts for particular diseases, which 
makes contracting with third parties much easier. 
Funds collected by the disease cluster group would 
be used first to reimburse traditional departments 
for the percentage of efforts that various specialists 
spend working with the cluster patients; then the 
institutional support and practice xpenses would be 
paid. The surplus would remain with the physicians 
in the cluster, offering opportunities for supplemen- 
tal compensation and further development of the 
cluster. 
One example of this in cardiac surgery has been 
introduced and worked out at New York Hospital- 
Cornell Medical Center by agreement among the 
several specialists treating coronary artery disease. 
A fixed price is established and negotiated with 
insurance companies to cover all costs of treating 
patients admitted with cardiac chest pain. The phy- 
sicians involved are in close contact and develop a 
treatment pathway based on the unique circum- 
stances of the individual patient rather than on 
specialty interest. All involved physicians receive 
compensation for the treatment of each patient 
entering the pathway, regardless of the final therapy 
given. A fixed percentage of the physician compo- 
nent of the fee is paid to the cardiothoracic surgeon, 
the cardiac anesthesiologist, the coronary care unit 
physician, the interventional cardiologist, and other 
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members of the team, regardless of what treatment 
the patient actually receives. This eliminates an 
economic aspect o competition among the special- 
ists and provides the most streamlined and efficient 
care tailored to the patient's need. 
At The New York Hospital-Cornell Medical Cen- 
ter, such disease cluster estructuring is now being 
implemented for heart, vascular, neurologic, neo- 
plastic, gastroenterologic, and adolescent medical 
diseases. Others are evolving naturally. Similarly, at 
Columbia-Presbyterian other clusters uch as pul- 
monary are in the process of formation. The newly 
opened Greenberg Pavilion of The New York Hos- 
pital is not structured along traditional departmen- 
tal lines. Rather, all patients with heart disease, 
whether medical or surgical, are placed in the same 
intensive care and inpatient units, and the nurses 
and staff are cross-trained to care for patients with 
heart disease. Similar geographic clusters are being 
implemented for patients with cancer, gastrointesti- 
nal diseases, neurologic diseases, and others. It is 
early in this experience, and as expected the funds 
flow issues are the most difficult. However, there is 
general physician enthusiasm to restructure along 
these lines. 
All of these changes force new thinking and the 
acquisition of different ypes of expertise among 
cardiothoracic surgeons. The choices that face us 
are multiple. If physicians are to retain the respon- 
sibility and control for quality of care and avoid a 
revolution based solely on economics and social 
decisions, each of us must become heavily involved 
in the resolution of patient, public, and professional 
choices. 
Fortunately, surgeons have many qualities to 
make them ideal as change agents. We are typically 
decision makers, risk takers, activists, responsive to 
our communities, and many have leadership skills. 
Hence most of us must become thoracic surgeons 
and something more or else we shall abandon our 
legacy and abandon the structure and control of 
medical care to people whose main concern is not 
the well-being of our patients. 
Cardiothoracic surgeons can participate in the 
health care revolution at different levels, including 
as individual practitioners, asmembers and leaders 
of our professional organizations, and as leaders of 
public or private institutions. As practitioners there 
are many places where we can be thoracic surgeons 
and something more. The quality of patient care at 
the local institution and surgical standards still rest 
with the practitioners. We must invest more into 
becoming educators of our patients, as well as of 
students, residents, and colleagues. We must all be 
active in our local communities as health care 
restructuring issues are addressed. Individual prac- 
titioners remain the source for advancing knowledge 
in our field, much as Julian Johnson insisted that we 
do in the first version of this theme. 
As leaders and members of our specialty organi- 
zations, we can strongly influence the setting of 
standards through the medical boards and peer 
review. We can set the content of professional 
education through a variety of structures in which 
we play a leadership role. We can help focus re- 
search that will determine the future of our specialty 
through our specialty society scientific programs, 
guidance of granting agencies, and through our 
medical school involvements. However, because our 
professional societies are too fragmented and do not 
control major resources, the ability to influence 
major public policy is rather limited. 
Some of us are given the opportunity to serve as 
leaders of public or private institutions. Fortunately 
a number of currently active and practicing thoracic 
surgeons have accepted such responsibilities, includ- 
ing our president-elect, Dr. Floyd Loop at the 
Cleveland Clinic, and a number of leaders in this 
association, both former and future presidents. As I 
commented at the time of my election to this 
position, I had never expected this to happen, 
because I thought hat accepting a major adminis- 
trative post would be viewed unfavorably by my 
thoracic surgical colleagues. I now realize that if we 
in our specialty do not accept and recognize such 
challenges, we will be left out of the decision-making 
process. I have had a splendid time continuing 
thoracic surgery while leading one of the country's 
great medical centers. I strongly urge any of you who 
have such an opportunity to do so. One can retain 
the practitioner role, retain the professional society 
role, and have a much more important opportunity 
to control resources and influence overall patient 
care and public policy. A few thoracic surgeons and 
other surgical specialists are called to participate 
through the political process, where a different kind 
of impact can be realized in helping to shape the 
revolution. Senator Bill Frist and former Surgeon 
General C. Everett Koop are outstanding examples 
of such opportunities. 
As a leader of a major academic health center, 
one does have to accept he responsibility for the 
future of medical practice within a broader commu- 
nity. The current revolution is certainly in mid- 
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campaign, and the struggle between physicians and 
hospitals triving to maintain quality while control- 
ling cost pits us strongly against financial forces 
represented by health maintenance organizations 
and insurance companies. In the early years of this 
revolution, it seemed as though the advantages were 
all with the insurers, who acquired the power to 
control individual physicians and institutions and 
determine patterns of patient care. It seemed that 
the best counteraction to this would be to create 
power in the hands of the providers o that the 
negotiation between payor and provider would take 
place on a level playing field and the interest of the 
physicians and public in quality care could be pro- 
tected. For this reason, over the past 7 years The 
New York Hospital has developed a corporately 
integrated network of providers, physician groups, 
nine general hospitals and six specialty hospitals, 
nursing homes, rehabilitation facilities, and more 
than thirty ambulatory sites scattered throughout 
New York City and Westchester County. 14 These all 
function under a single corporate parent, which I 
have been privileged to lead. 
Consideration f the future of this network and its 
ability to improve patient care quality were the 
major factors in our recent decision to merge The 
New York Hospital and The Presbyterian Hospital 
in the City of New York. Both New York-Cornell 
and Columbia-Presbyterian are justifiably world fa- 
mous institutions, but their centers of excellence are 
complementary to each other and not competitive. 
It seems obvious that quality for all the patients 
within our system would be improved if we brought 
together the excellence of these two major institu- 
tions at the core of the health care system. A second 
factor was accessibility. The New York Hospital 
Healthcare System largely included Brooklyn, 
Queens, and the eastern portion of Westchester 
county, whereas the Presbyterian affiliates were 
largely in the Hudson River Valley on both sides of 
the river including institutions in New Jersey, upper 
Manhattan, the Bronx, and Westchester County. 
Bringing these two centers and their corporately 
sponsored affiliates together now means that ap- 
proximately 15% of all inpatient health care in New 
York City and Westchester County is provided by a 
single entity. The power of this market penetration 
has become evident in our recent successes in 
contracting with health maintenance organizations 
in the newly deregulated New York State medical 
economy. Some cost savings will be achieved, but 
the main reasons for this merger have been the 
extension of quality to a broader segment of the 
public and an increased market share. 
When the power of institutions uch as New 
York-Cornell and Columbia-Presbyterian is fo- 
cused, much can be achieved. On this very day, the 
first patients are moving into the new Greenberg 
Pavilion of The New York Hospital. The need for 
this facility was acknowledged 25years ago. In the 
past 9 years, it has become a reality through the 
work of many people. Among the road blocks 
encountered was the need to obtain 43 separate 
federal, state, and city licenses and endorsements. It 
was possible to break through the bureaucracy that 
seems stifling and contrary to the good of our 
patients and our profession. However, considerable 
public support can be mobilized for quality care and 
forward planning about the future of American 
health care. I have been privileged to participate in 
all of this and, I hope, added something more to an 
otherwise totally satisfying career as a thoracic sur- 
geon. Fortunately, many of our colleagues have 
made similar choices and are making a difference. 
I strongly believe that this current revolution can 
be shaped to preserve quality as our first objective. 
Admittedly cost must be controlled, but we know 
how to do that better than anyone lse does, and our 
commitments include accessibility to all of our citi- 
zens regardless of ability to pay. 
This strong belief is buttressed and shared with a 
family that is fully committed to the improvement in 
quality health care. My wife of more than 40 years, 
Ellie, is the daughter of two distinguished Cleveland 
academic physicians, and Ellie has always guided my 
decisions based on excellence and what is right for 
patients. Her mother still lives with us at age 92 
years and still is focused on quality of patient care. 
Our four daughters have each played an important 
role in sustaining these family objectives. Linda, our 
oldest, is an assistant professor of surgery at the 
University of Pennsylvania and married to David 
Callans, an interventional cardiologist in Philadel- 
phia. They have two delightful children. Our second 
daughter, Kristen, is an assistant professor of sur- 
gery at the University of Southern California. Both 
surgeon daughters include research as well as clini- 
cal practice and teaching in their daily lives. Our 
third daughter fortunately brings an artistic interest 
into the family as a theatrical lighting and stage 
designer in Rochester, New York. She is married to 
Roger Rowley, a photographer and gallery manager 
and the son of two of the University of Chicago's 
most distinguished physicians. Carise and Roger 
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have a splendid baby girl. Our  fourth daughter,  
Margaret ,  is an environmental  engineer for Peoples 
Energy in Chicago and is also the current pres ident 
of the Junior Chamber  of Commerce of  Chicago. 
She is finishing a premedical  educat ional  course and 
applying for medical  school next year. Throughout  
my life my brother,  Don,  has been my closest fr iend 
and advisor. He has a remarkably dist inguished 
career as professor of urology at the University of 
Southern Cal i fornia and is recognized as one of the 
world's great pelvic surgeons. He too is blessed with 
an outstanding wife, Shirley, and a wonderful  family. 
My entire family is here today and I would ask them 
to stand and join with me in thanking you for the 
great opportuni ty  and honor  you have given me this 
year. They are all as committed as I am that quality 
of care must carry the day as this revolut ion plays 
itself out. 
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